CORTISOL, PHYSICAL ACTIVITY, AND WEIGHT LOSS  IN A RANDOMIZED CLINICAL TRIAL by Smith, Shawn S.
University of Kentucky 
UKnowledge 
Theses and Dissertations--Dietetics and Human 
Nutrition Dietetics and Human Nutrition 
2014 
CORTISOL, PHYSICAL ACTIVITY, AND WEIGHT LOSS IN A 
RANDOMIZED CLINICAL TRIAL 
Shawn S. Smith 
University of Kentucky, big3s1987@gmail.com 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Smith, Shawn S., "CORTISOL, PHYSICAL ACTIVITY, AND WEIGHT LOSS IN A RANDOMIZED CLINICAL 
TRIAL" (2014). Theses and Dissertations--Dietetics and Human Nutrition. 25. 
https://uknowledge.uky.edu/foodsci_etds/25 
This Master's Thesis is brought to you for free and open access by the Dietetics and Human Nutrition at UKnowledge. 
It has been accepted for inclusion in Theses and Dissertations--Dietetics and Human Nutrition by an authorized 
administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my thesis or dissertation and abstract are my original work. Proper attribution 
has been given to all outside sources. I understand that I am solely responsible for obtaining 
any needed copyright permissions. I have obtained needed written permission statement(s) 
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine) which will be 
submitted to UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s thesis including all 
changes required by the advisory committee. The undersigned agree to abide by the statements 
above. 
Shawn S. Smith, Student 
Dr. Kelly Webber, Major Professor 
Dr. Kelly Webber, Director of Graduate Studies 
 
 
 
 
 
 
 
 
CORTISOL, PHYSICAL ACTIVITY, AND WEIGHT LOSS 
 IN A RANDOMIZED CLINICAL TRIAL 
 
 
 
 
 
__________________________________ 
 
THESIS 
__________________________________ 
 
 
A thesis submitted in partial fulfillment of the  
requirements for the degree of Master of Science in the  
College of Agriculture, Food and Environment  
at the University of Kentucky  
 
By 
 
Shawn S. Smith 
 
Lexington, Kentucky 
 
Director: Dr. Kelly Webber, PhD, MPH, RD, LD 
 
Lexington, Kentucky 
 
2014 
 
Copyright © Shawn S. Smith 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT OF THESIS 
 
 
 
 
CORTISOL, PHYSICAL ACTIVITY, AND WEIGHT LOSS 
 IN A RANDOMIZED CLINICAL TRIAL 
 
 
 Abnormal cortisol levels may be an important factor in the ability of an individual 
to lose weight and maintain weight loss. This study examined overweight and obese 
individuals who participated in a weight loss program. Cortisol, physical activity, and 
weight loss were measured at regular intervals and examined for possible relationships 
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Chapter 1. Introduction 
 
 Booming obesity rates plague America, affecting both adolescents and adults. 
Obesity is associated with numerous diseases such as diabetes, heart disease, and certain 
cancers. Reducing the prevalence of obesity is of paramount concern (Carlson and 
Gerrier, 2006).  According to a recent study, the U.S. is expected to spend $344 billion on 
health care costs attributable to obesity in 2018 if obesity rates continue to increase at 
their current rates. This estimate would translate to obesity-related expenditures 
accounting for more than 21% of the nation's direct health care spending in 2018 (United 
Health Foundation, 2009). As such, it is of great importance that initiatives are taken to 
combat the escalation in obesity in America. 
 Shifting from an obese state towards a healthier body weight reduces many health 
risks associated with obesity such as insulin resistance, diabetes mellitus, hypertension, 
dyslipidemia, sleep apnea, hypoxemia and hypercarbia, and osteoarthritis (Pi-Sunyer, 
1993). Unfortunately, a reduction and sustained weight loss can be a very daunting task 
for most individuals. According to an NHANES study conducted between 1999 and 
2006, 35% of total participants surveyed (n=14,306) were successful at maintaining a 
weight loss of at least 5% for more than a year (Kraschnewski et al., 2010). However, 
intensive, structured, behavioral-based programs can result in a significant amount of 
weight lost (Anderson et al., 2001). Many of these programs encompass calorie 
restriction, progressive physical activity, and lifestyle and behavioral changes (Hill, 
Thompson, & Wyatt, 2005). Even still, many individuals fall short of their weight loss 
goals despite adherence to a weight loss program.  
 Exercise, dieting, and behavioral modifications are not the only determinants of 
body weight. Genetic, hormonal, and metabolic factors heavily influence body weight 
and condition (Anderson et al., 2001). The overabundance or lack of cortisol, a stress-
related hormone, may be a key player in the ability of an individual to reduce and 
maintain body weight. When stress is induced via intrinsic or extrinsic forces, a myriad of 
physiological responses are produced in the body in order to reestablish equilibrium. One 
such physiological adaption is the release of cortisol. Studies have shown abnormally 
high or low cortisol concentrations are related to dysregulation of the hypothalamic-
pituitary-adrenal axis (HPA), chronic stress, upper body fat, and insulin resistance (Bose 
et al., 2009). Abnormal cortisol production has also been positively linked with obesity 
and impaired carbohydrate metabolism (Rosmond et al., 2000). More notably, obesity has 
been proposed to produce a chronic, stressful state which is characterized by a wide range 
of diseases and symptoms including metabolic syndrome (Kyrou et al., 2006). In 
summary, these conditions associated with cortisol abnormalities seem to create an 
undesirable environment for optimal weight loss. 
 If excessive cortisol does in fact inhibit normal metabolic function, it would be 
beneficial to conduct research that explores possible mechanisms leading to 
overproduction. Low intensity physical activity is one promising approach to cortisol 
reduction. A study conducted in 1992 showed that brisk walking and other forms of low-
intensity exercise improved mood, lowered salivary cortisol, and improved resting heart 
rate and blood pressure (Jin, 1992). If such a relationship exists, adopting a low-intensity 
exercise program may provide an appropriate treatment for both lowering of cortisol and 
reduction of bodyweight in obese individuals. Analyzing cortisol levels in obese and 
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overweight individuals may also present a possible hormonal and metabolic explanation 
as to why individuals fail to lose weight despite caloric restriction and increased physical 
activity. If such a correlation is present, it could provide a new strategy to reduce the risk 
of obesity.  
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Chapter 2. Methodology 
 
Research Purpose 
The purpose of this research is to add to the body of knowledge exploring the relationship 
of cortisol, obesity, and weight loss. The main objective of this research is to determine if 
excessive cortisol levels at baseline suppress the ability of obese adults to lose weight 
during a weight loss program. The central hypothesis for this research is that individuals 
who have elevated levels of cortisol at baseline will fail to produce significant weight loss 
at 10 and 20 weeks follow-up. Additionally, increasing levels of physical activity will be 
correlated with decreasing levels of cortisol at 10 and 20 weeks follow-up. 
 
Research Questions 
 
 Is there a correlation between baseline cortisol levels in research 
participants and weight loss at 10 and 20 weeks? 
 Does cortisol at 10 weeks predict weight lost at 20 weeks? 
 Is there a correlation between week 20 cortisol levels and weight loss at 20 
weeks? 
 Is there a correlation between change in physical activity level and change 
in cortisol levels from baseline to 10 weeks and baseline to 20 weeks? 
 
Study Design:  
This was a two group randomized experimental design study.  One group received a 
standard weight loss program and one group received a stress management based 
intervention built on research in neuroscience and principles of the attachment theory. The 
active intervention portion of the study lasted ten weeks and a follow-up (no face-to-face 
contact) period of ten weeks occurred before final evaluations. There was no deception 
involved in this study.  
 
Study Population:  
The study was conducted from February to July 2014.  Both males and females were 
recruited.  After providing written consent and a signed physician’s consent form, along 
with completing baseline assessments, individuals (n=49) were randomized to one of two 
groups, each of which received a 10-week face-to-face intervention.  The 10-week 
intervention period was followed by a 10-week low-contact period to assess maintenance 
of changes. 
 
Inclusion criteria: Participants must have (1) been 25-55 years of age (2) had a BMI of > 
28 and <45  (3) met criteria for at least one additional risk factor for metabolic 
syndrome (waist circumference or blood pressure) (4) owned and used a smartphone. 
 
Exclusion criteria: Participants must not have: (1) had a medical diagnosis of orthopedic 
or joint problems that may have prohibited regular exercise; (2) endorsed any of the 
first three items on the Physical Activity Readiness Questionnaire (PAR-Q): heart 
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problems, chest pain, faintness or dizzy spells; (3) endorsed any of the other items on 
the PAR-Q without a physician’s consent; (4)  had a hospitalization for a psychiatric 
disorder within the last year; (5) had a history of anorexia or bulimia nervosa; (6) had 
a medical diagnosis of cancer or HIV; (7) had a diagnosis of a major psychiatric 
disorder (i.e. bipolar disorder or schizophrenia) or taken anti-psychotic medications; 
(8) been pregnant, nursing, or planning to become pregnant within the study period; 
(9) been less than 9 months post-partum; (10) had a weight loss of > 10 pounds in the 
last six months; (11) been on more than two medications for hypertension control; 
(12) greater than stage 3 kidney disease; (13) been taking insulin to control diabetes; 
(14) been taking Coumadin; (15) been taking Lasix (16) and anyone, who in the 
opinion of the study investigators, were not considered a good candidate for the 
study.   All of this information was self-reported in the initial screening phone call.  
 
Dr. Webber and the research assistant conducted study information sessions for potential 
participants during January and February 2014.  These sessions were conducted in a 
classroom at the University of Kentucky.  Interested and qualified participants were asked 
to receive approval from their primary care physician, sign study consent forms, and fill 
out questionnaires: Demographics, Paffenbarger Physical Activity Questionnaire 
(Ainsworth et al., 1993), the Center for Epidemiological Studies Depression Scale 
(Radloff, 1977), the Perceived Stress Scale (Cohen, Kamarck, and Mermelstein, 1983 and 
Cohen and Williamson, 1988), the Block 2005 Food Frequency Questionnaire (Block et 
al., 1990), the Yale Food Addiction Scale (Gearhardt et al., 2008), the Eating Attitudes 
Test-26 (Garner et al., 1982 and Mintz and O'Halloran, 2000), and the Short Form-36 
Quality of Life Survey (Melville et al., 2003). Participants were also asked to schedule 
appointments at the UK Clinical Research Development and Operations Center (CR-
DOC) for baseline assessments of height, weight, waist circumference, blood pressure, 
and blood draw for fasting blood glucose, insulin, high sensitivity c-reactive protein, lipid 
panel, and telomere length.  The cortisol mouth swab was dropped off at the lab at this 
time.  Once measurements at the CR-DOC were taken, participants were randomized to 
study group. 
 
Each study group was divided into smaller groups of 8 or 9 participants each.  Each 
group met once per week (90 minute sessions) for ten weeks at the offices of the certified 
Emotional Brain Training (EBT) provider or on campus in a classroom or conference 
room with a Registered Dietitian. The stress management (EBT) based group followed 
the Wired for Freedom weight loss book provided by the Institute for Health Solutions 
and was led by the certified EBT provider. The control group received weekly group 
sessions based on the Diabetes Prevention Program for ten weeks provided by the Project 
Coordinator or Dr. Webber, both registered dietitians.  
 
During the first week of the study, subjects were instructed to wear a New Lifestyles-
1000 (NL; LeesTown, MO) medical grade activity monitor for 7 consecutive days. This 
monitor was chosen for its simplicity, durability, low cost, seven-day memory capability, 
accuracy, reliability, and ability to assess time spent in moderate-to-vigorous activity. The 
subjects were instructed to place the activity monitor on their waistband at the anterior 
midline of the thigh, on the right side of the body, according to manufacturer’s 
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recommendations. Subjects placed the monitor on their waistband (or a nylon belt 
provided) upon awakening in the morning and took it off when they went to bed at night, 
unless they came into contact with water (e.g., bathing and swimming). To avoid 
reactivity, all activity monitors were sealed using stickers after stride length, time of day, 
and an intensity threshold were internally programmed. Stride length was measured by 
the average of two- 20 step “normal length and paced” walks down a hallway corridor. 
The researchers set the NL activity monitor moderate-to-vigorous physical activity 
(MVPA) threshold at an appropriate activity setting for the subjects (setting #3), based on 
recommendations from the manufacturer.   
 
Participants were contacted and scheduled for an assessment visit at 10 weeks conducted 
at the CR-DOC.  Participants were given a cortisol mouth swab kit, instructions, ice 
packs, and a small container.  Participants were asked to use the kit to get a cortisol 
sample immediately on awakening or between 7 and 9 am on the morning before their 
visit at the CR-DOC lab. The same measurements and assessments completed at baseline 
were taken at 10 weeks, with the exception of height. Each participant received $50 for 
attending the 10-week assessment to ensure adequate follow-up rates. Participants were 
again asked to wear the New Lifestyles-1000 activity monitors for seven days. The 
monitors were given out at the 10 week face-to-face group session and participants were 
asked to return in one week to drop off the monitors.   
 
The last 10-weeks of the study involved only email and phone call contact with 
participants.  No face-to-face groups were conducted.   
 
At week 19 participants were asked to come in and get the physical activity monitors to 
use for the last week of the study.  Participants were again asked to wear the New 
Lifestyles-1000 activity monitors for seven days. The monitors were retrieved from 
participants at their final assessment visit at the lab.  Participants were given a cortisol 
mouth swab kit, instructions, ice packs, and a small container.  Participants were asked to 
use the kit to get a cortisol sample immediately on awakening or between 7 and 9 am on 
the morning before their visit at the CR-DOC lab. 
 
Participants were contacted and scheduled for an assessment visit at 20 weeks to be 
conducted at the CR-DOC. The same measurements and assessments taken at baseline 
were taken at 20 weeks, with the exception of height. Each participant received $75 for 
attending the 20-week assessment to ensure adequate follow-up rates. Participants were 
also mailed all of their lab values if they completed the entire study and all three 
assessments. 
 
Statistical Methods: 
 
Descriptive statistics were used to characterize the sample. Data were checked using the 
Kolmogorov-Smirnov test for normality (McClave, Dietrich, and Sincich, 1997). Data 
were not normally distributed, so nonparametric tests were used. Spearman's rho was 
used to test for correlations (McClave, Dietrich, and Sincich, 1997). Linear regression 
was used to predict 20-week weight loss. 
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Chapter 3. Literature Review 
 
Weight Loss: Safe, effective methods 
 
 Weight loss is, quite logically, the primary solution to obesity. Surgical procedures 
are effective as well, but are only recommended to select candidates. There are a vast 
array of methods available to an individual attempting to lose weight. However, not all 
are widely accepted as safe and effective. According to the 2013 American Heart 
Association/American College of Cardiology/The Obesity Society Guideline for the 
Management of Overweight and Obesity in Adults, an energy deficit is required to lose 
weight and the following dietary techniques are an acceptable means to do so: 
 
 "Specification of an energy intake that is less than that required for energy 
balance, usually 1,200 to 1,500 kcal/day for women and 1,500 to 1,800 kcal/day for men 
(kcal levels are usually adjusted for the individual's body weight and physical activity 
levels); Estimation of individual energy deficit of 500kcal/day or 750kcal/day or 30% 
energy deficit; and Ad libitum approaches where a formal energy deficit is not prescribed, 
but lower calorie intake is achieved by restriction or elimination of particular food groups 
or provision of prescribed foods." 
 
        (Jensen MD, et al., 2013) 
 
 Along with a reduced-calorie diet, physical activity and behavioral therapy are 
also integral parts of many successful weight loss programs. The following parameters 
describe how effective, on-site comprehensive-lifestyle interventions address physical 
activity and behavioral therapy: 
 
 "...increased physical activity (such as brisk walking) for > 150 minutes/week 
(equal to > 30  minutes/day, most days of the week). Higher levels of physical activity, 
approximately 200 to  300 minutes/week, are recommended to maintain lost weight or 
minimize weight regain long-term (>1 year)."  
 
 "Comprehensive lifestyle interventions usually provide a structured behavior 
change program that includes regular self-monitoring of food intake, physical activity, 
and weight. These same behaviors are recommended to maintain lost weight, with the 
addition of frequent (i.e. weekly or more often) monitoring of body weight." 
 
        (Jensen MD, et al., 2013) 
  
 The importance of calorie reduction, increased physical activity, and self-
monitoring behaviors is of chief importance in weight loss maintenance as well. The 
Look AHEAD study provided data that showed those who maintained a greater than 10% 
weight loss at the conclusion of the study all practiced high levels of physical activity, 
reduced caloric intake, and monitored their bodyweight frequently (Wadden, et al., 2014). 
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Cortisol: Profile and Functions 
 
 Hormones are extremely powerful molecules manufactured in the human body. 
They are used for communication between tissues with the ultimate goal of regulating 
bodily processes and behaviors. There are over fifty different hormones in the human 
body, each with a specific host of functions. When released from a gland via the network 
known as the endocrine system, the hormone travels to the target tissue to transmit 
information that will lead to a specific action. 
 Cortisol, a hormone produced in the adrenal glands, is a glucocorticoid whose 
main function is to restore homeostasis as a result of the stress response. Whenever a 
stress response is triggered or a low blood sugar level is detected, cortisol is released 
from the adrenal cortex and is used to stimulate the process of gluconeogenesis in the 
liver. As glucose is formed from various amino acids, blood sugar rises and more energy 
is available. Cortisol also plays an important role in glycogenolysis, an important process 
for utilization of potential energy that also ultimately leads to an increase in blood 
glucose levels. Cortisol is simply the key to activating the mechanisms which ensures a 
steady supply of glucose to the body. 
 In addition to metabolic function, cortisol plays a role in immune function. 
Cortisol prevents an over-activation of the inflammatory response. This is beneficial 
because chronic inflammation leads to damaging of tissue. Cortisol keeps inflammation 
in check by blocking T-cell proliferation and inhibition of histamine secretion. This is 
mimicked in the pharmaceutical world, where derivatives of cortisol such as 
hydrocortisone and prednisolone are used as means to control inflammation and suppress 
the immune response. 
  
Hypercortisolism Among the Obese 
 
 Obesity is a known characteristic of hypercortisolism (Cushing's Syndrome), but 
it is still unclear as to whether hypercortisolism is a characteristic of obesity. Signs and 
symptoms of hypercortisolism are: upper body obesity, severe fatigue and muscle 
weakness, high blood pressure, backache, elevated blood sugar, easy bruising, and bluish-
red stretch marks on the skin. Prolonged periods of synthetic glucocorticoid steroids, 
tumors of the pituitary glands and adrenal glands, and ectopic adrenocorticotropic 
hormone (ATCH) are all common causes of hypercortisolism. Currently, there is no 
consensus in the literature concerning the relationship between obesity and high levels of 
cortisol.  
 Strain, Zumoff, Levin, and Fukushima (1980) found that there was not a 
significant elevation of cortisol production due to obesity, but with greater increases in 
lean body mass. However, it has also been suggested that an increase in visceral fat 
accumulation positively correlates to elevated cortisol secretion in women (Marin et al., 
1992). This suggests that both added muscle mass and fat mass contribute to higher levels 
of cortisol. This is evidenced by a study conducted by Mlynaryk, Gillies, Murphy, and 
Pattee (1961) which concluded that production of cortisol is proportional to bodyweight 
in general.  
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Weight Loss and Cortisol Levels 
 
 Hormonal changes occur within the body when bodyweight is dramatically lost or 
gained. The HPA (hypothalamic-pituitary-adrenal) axis, which controls cortisol 
production, is particularly subject to altered function when such a weight change occurs. 
However, the direction in which weight loss influences cortisol levels remains 
controversial. 
  Massive weight loss among morbidly obese subjects has been shown to increase 
free cortisol and decreased cortisol binding globulin levels (Manco et al, 2007). This 
increase in cortisol levels with massive weight loss may occur due to an adaptive 
phenomenon related to environmental changes which induced stress. Cortisol levels have 
also been increased due to weight reduction among subjects with depression, suggesting 
weight loss does account for changes in the functioning of the HPA axis (Casper et al, 
2007). 
 In obese vs healthy weight children, obese children with insulin resistance had 
higher levels of cortisol than healthy weight children. Upon weight reduction, the obese 
children with insulin resistance experienced a decrease in cortisol levels (Reinehr et al, 
2004). Diet may also play a contributing factor in the way in which weight loss 
influences cortisol production. Johnstone, Faber, and Andrew (2004) found that obese 
men who lost weight with a very low calorie diet vs starvation normalized their cortisol 
production from an over-productive state. 
 There seems to be several covariates in the relationship between weight loss and 
cortisol production. Given the complex and intricate function of the endocrine system and 
the HPA axis, well-controlled studies are needed in order to draw more solid conclusions 
concerning this relationship. 
 
Effects of Physical Exercise on Cortisol Levels 
 
 Physical activity promotes many favorable effects on the human body such as 
weight control, reduced risk of certain major chronic diseases, strengthening of tissues, 
and improvement in mental health and energy. Many of these benefits are a result of the 
action of hormones in the body. Growth hormone is released during and after intense 
anaerobic exercise, boosting protein synthesis, body fat catabolism, energy production, 
and well-being. Insulin production and sensitivity are also improved through regular 
exercise. Cortisol, the stress-related hormone, is no exception to stimulation when 
exercise occurs. 
 The degree to which cortisol is affected by exercise seems to be dependent on 
several variables. Kindermann et al. (1982) examined exercise duration and intensity on 
cortisol concentrations by assigning participants to three different treadmill regimes. 
Upon completion of the physical activities, it was determined an anaerobic intensity and 
longer duration increased cortisol levels more than aerobic intensity and shorter exercise 
periods. These relationships can also be seen in studies conducted by Hill et al. (2008) 
and Farrell et al. (1983). Higher intensity exercises such as sprinting resulted in stronger 
releases in cortisol while lower intensity exercises such as yoga led to a much lower 
release of cortisol or sometimes an improvement of baseline cortisol levels. Duration, no 
matter what form of exercise used, also had a positive relationship with cortisol release.  
8
 When a stressful event such as exercise stimulus occurs, the body responds by 
releasing cortisol. Therefor, an individual who exercises regularly experiences more 
frequent cortisol responses when compared to an inactive individual. This leads to 
speculation as to whether this response is desensitized when routinely mediated through 
physical exercise. If this theory were true, regularly active individuals would experience a 
blunted cortisol response to exercise when compared to inactive individuals. Rudolph and 
McAuley (2010) compared the cortisol response of 13 male cross-country runners and 13 
non-runners after bouts of 30 minute exercise on a treadmill. At the conclusion of the 
experiment, no significant group differences in cortisol responses were found. However, 
perceived exertion was positively related to post-exercise cortisol levels in both groups, 
suggesting a subjective component playing a role in the cortisol response. 
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Chapter 4. Results 
 
Descriptive Statistics 
 
 The population sample (n=49) had a mean baseline BMI of 36.56 (±4.45) kg/m2, a 
mean age of 44.69 (±8.36) years and a mean baseline waist circumference of 43.15 
(±4.37) inches. The sample was mostly non-Hispanic white (n=40, 81.6%), 14.3% (n=7) 
was African-American, 2% (n=1) was Hispanic/Latino, and 2% (n=1) was Asian. Out of 
the entire population sample, 16.3% (n=8) were male and 83.7% (n=41) were female. 
Marital status data was collected, and 69.4% (n=34) were married, 14.3% (n=7) were 
divorced, 14.3% (n=7) were never married, and 2% (n=1) was not reported. 
Graduate/Professional degrees were earned among 20.4% (n=10) of the sample 
population, 34.7% (n=17) earned Bachelor's degrees, 22.4% (n=11) had some college 
coursework, 18.4% (n=9) earned Associate's degrees, and 4.1% (n=2) earned a High 
School degree. Mean baseline steps taken per week was 33,232.56 (±15363.76), mean 
baseline moderate to vigorous physical activity (MVPA) in minutes per week was 75.67 
(±61.77), and mean baseline cortisol levels were 0.46 (±.43). 
         
        Table 4.1 Physical Characteristics of the Population Sample 
Note: BMI, Waist Circumference, and Age are given as mean ± standard deviation 
 
   
                   Table 4.2 Baseline Physical Activity and Cortisol Level 
Note: Steps Per Week, MVPA, and Cortisol Levels are given as mean ± standard 
deviation 
 
Predictors of Weight Loss 
 
 There was no correlation between baseline cortisol levels and weight loss at either 
10 weeks (r=0.24, p=0.12) or 20 weeks (r=0.07, p=0.65). Cortisol levels at 10 weeks did 
correlate with greater weight lost at 20 weeks (p=0.05). The linear regression model 
explained 7% of the variance weight loss when baseline and 10-week cortisol levels were 
included. There was no correlation between week 20 cortisol levels and weight loss at 20 
weeks (r= 0.18, p=0.25).  
 There was no correlation between number of minutes in MVPA and change in 
cortisol levels between baseline and 10 weeks (r= 0.17, p=0.29) or baseline and 20 weeks 
(r= 0.04, p=0.82). Number of steps was also not correlated with change in cortisol levels 
between baseline and 10 weeks (r=0.26, p=0.11) or baseline and 20 weeks (r=0.03, 
p=0.84).  
 
  
 
 
Steps Per Week MVPA in Minutes Cortisol Levels
33,232.56 ± 15363.76     75.67 ± 61.77 0.46 ± 0.43
Waist Circumference (inches) Age (years)BMI (kg/m²)
36.56 ±  4.45 43.15 ±  4.37 44.69 ±  8.36
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Table 4.3 Cortisol Levels among Groups 
 
       Baseline    10 weeks    20 weeks 
Emotional Brain Group 0.42 ± 0.53 0.39 ± 0.22 0.52 ± 0.57 
Registered Dietitian Group 0.50 ± 0.31 0.46 ± 0.32 0.42 ± 0.2
Note: Cortisol levels are given as mean ± standard deviation 
 
 
Table 4.4 Moderate-to-Vigorous Physical Activity (in minutes) among Groups 
  
       Baseline                     10 weeks                      20 weeks  
  
Emotional Brain Group 80.17 ± 65.55 96.13 ± 76.62 69.04 ± 61.04 
Registered Dietitian Group 70.95 ± 58.72 102.71 ± 103.46 69.2 ± 93.14
Note: MVPA is given as mean ± standard deviation 
 
 
Table 4.5 Steps per Week among Groups 
 
      Baseline        10 weeks        20 weeks 
Emotional Brain Group 34546.26 ± 15889.90 38048.58 ± 19333.42 30751.71 ± 24009.56 
Registered Dietitian Group 31859.14 ± 15039.68 36688.29 ± 24000.36 26469.76 ± 25704.95
Note: Steps per week is given as mean ± standard deviation 
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Chapter 5. Discussion 
 
 The first goal of this study was to determine if there was a correlation between 
baseline cortisol levels and weight loss at 10 or 20 weeks. It was hypothesized that a 
higher baseline cortisol level would negatively influence weight loss at 10 and 20 weeks. 
It was determined there was no correlation between weight lost at 10 weeks (p=0.12) or 
20 weeks (p=0.65) with baseline cortisol levels. Previous findings both support and 
oppose a correlation between these two variables. Manco et al. (2007) found subjects 
who lost a significant amount of weight both increased free cortisol levels and decreased 
cortisol binding globulin levels. Johnston, Faber, and Andrew (2004) encountered 
normalizing of their subject's cortisol levels after weight loss. All of these studies utilize 
different weight loss methods and programs along with different subjects with various 
conditions and co-morbidities. This large variance in research design among this and 
other studies performed in the past may explain the lack of consistent evidence 
supporting a relationship between cortisol and weight loss. 
 The second goal of this study was to determine if cortisol levels at 10 weeks were 
related to weight loss at 20 weeks. A hypothesis was formulated that supported the theory 
of higher cortisol levels at 10 weeks with an impedance of weight lost at 20 weeks. 
Results determined that the inverse of the hypothesis occurred. In a linear regression 
model, cortisol levels at 10 weeks predicted weight loss at 20 weeks. Previous studies 
provide a mixture of conclusions, but the overall catabolic nature of cortisol may explain 
the relationship seen in this study. Since cortisol's primary function is to raise blood sugar 
through gluconeogenesis, it is intuitive to interpret cortisol elevation with increased 
utilization of protein and fat for energy. With chronic catabolic metabolism, one might 
expect bodyweight to continually fall given the constant proteolysis and lypolysis 
occurring in the body to sustain energy levels. 
 The third objective was to examine a possible relationship between cortisol levels 
at 20 weeks and weight loss at 20 weeks. It was hypothesized that cortisol levels at 20 
weeks would be higher among participants who lost the least amount of weight. No 
correlation was found between cortisol at 20 weeks and weight loss at 20 weeks. Reinehr 
et al. (2004) discovered that obese children with insulin resistance experienced a decrease 
in cortisol levels after weight reduction. The difference between this study and the results 
might be from utilizing all diabetic participants. Since insulin and cortisol work 
antagonistically from one-another, cortisol may behave differently in humans with 
compromised insulin function. 
 The final goal of this study was to determine whether a relationship exists 
between change in activity levels and cortisol levels from baseline to 10 weeks and 
baseline to 20 weeks. It was hypothesized that higher activity levels would result in lower 
cortisol levels in both time periods. Two methods of measuring physical activity were 
used: minutes of moderate-to-vigorous physical activity (MVPA) and total number of 
steps. Neither measure of physical activity was related to change in cortisol levels at 10 
or 20 weeks. Studies conducted by Hill et al. (2008) and Farrell et al. (1983) determined 
that longer, more intense exercise (with which MVPA is analogous) was related with 
larger releases of cortisol when compared to lower intensity exercise such as yoga. With 
the instruments used to collect physical activity data in this study, it was impossible to 
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determine if and how long lower-intensity exercise was performed. Additionally, the 
previous studies measured cortisol immediately post-exercise. Since cortisol was 
measured in 10 week intervals in this study upon waking, any acute interpretation of the 
cortisol response to exercise would be null. 
  
Strengths, Limitations, and Future Research 
 
 One strength of this study was the length of time and manner of which physical 
activity data was collected. Physical activity was recorded via New Lifestyles-1000 
activity monitor which kept track of movement over three seven-day periods. If worn 
appropriately, the activity monitors provide a reliable and accurate method of recording 
physical activity. An accurate depiction of physical activity was important in determining 
potential relationships with cortisol and weight loss data. Another strength of this study 
was the high retention rate which resulted in a good amount of data collected by the end 
of the study. This could have been due to monetary compensation, regular follow ups and 
monitoring, and relatively non-invasive methods of data collection given the 
comprehensive nature of all variables examined. 
 This study encountered several limitations. One of the main limitations of the 
study was the amount of participants examined. Only 49 participants were included in 
data collection and slightly fewer had full data at the conclusion of the study. Increasing 
participant sample sizes could have led to more sensitive analysis. 
 Another limitation of this study may have been the methods of which cortisol was 
measured. Over a 20-week period, salivary cortisol was measured at baseline, and at 10 
and 20 weeks. Since cortisol levels rise and fall systematically in a diurnal pattern, 
measurements may read drastically different according to the time of day. A salivary 
cortisol test only provides a small window in which to study an individual's cortisol 
patterns. In order to determine if a chronic pattern of cortisol elevation or suppression is 
occurring, 24-hour urinary cortisol tests or midnight plasma cortisol tests might be more 
appropriate. 
 If more work were to be conducted concerning this topic, more controls need to 
be put in place in order to help delineate the relationship between cortisol and weight 
loss. Previous studies predominantly study subjects with one or more severe co-
morbidities, varying dietary approaches, and inconsistent exercise intensities. An ideal 
study would implement standardized weight loss diets along with low to moderate 
intensity exercise in order to minimize stress and the associated cortisol response.  
 
Conclusion 
 
 The results of this study provided little solid evidence supporting the influence of 
cortisol on the ability to lose weight. In fact, cortisol levels predicted quite the opposite of 
what was expected by the end of the research study. However, this process helps to 
illustrate the complexity and unpredictable nature of human metabolism. Hormones are 
responsible for several different roles in our bodies. As a biological machine, our bodies 
work in a symphony of processes that interplay and influence one-another, making the 
isolation of one sole variable difficult to explain a cause and effect model in the human 
body. 
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